A Case of Superficial Thrombo-occlusive Vascular Disease in a Patient With Rheumatoid Arthritis
Open Access
- 1 July 2022
- journal article
- editorial
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 29 (3) , 187-189
Abstract
Seong-ji Park, M.D., Chung-il Joung, M.D., Seung Hyun Cheong, M.D., Han Young Ryu, M.D., Ga Hyun Lee, M.D., Gil Jae Pyo, M.D., Mihye Kwon, M.D.. J Rheum Dis 2022;29:187-9. https://doi.org/10.4078/jrd.2022.29.3.187Keywords
This publication has 9 references indexed in Scilit:
- Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?International Journal of Molecular Sciences, 2021
- Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world dataAnnals of the Rheumatic Diseases, 2020
- Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐AnalysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBaseDrug Safety, 2020
- Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialThe Lancet Haematology, 2017
- Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trialThe Lancet Haematology, 2016
- Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort studyAnnals of the Rheumatic Diseases, 2014
- A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseasesArthritis Research & Therapy, 2014
- Livedoid VasculopathyArchives of Dermatology, 2006